Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Galapagos signs chemistry pact

September 11, 2006 | A version of this story appeared in Volume 84, Issue 37

Galapagos' BioFocus DPI chemistry services unit has entered a discovery deal with OneWorld Health, a nonprofit drug company based in San Francisco and backed by the Bill & Melinda Gates Foundation and other donors. BioFocus will apply its medicinal chemistry expertise to identify new drug candidates for OneWorld's diarrheal disease program. Galapagos says the pact is worth about $4 million over two-and-a-half years.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.